RISK OF INCIDENT HEPATOCELLULAR CARCINOMA IN HEPATITIS B-INFECTED PATIENTS TREATED WITH TENOFOVIR DISOPROXIL FUMARATE VERSUS ENTECAVIR: A US ADMINISTRATIVE CLAIMS ANALYSIS Kim, W., Telep, L., Lu, M., Ramroth, H., Flaherty, J. F., Gaggar, A., Chokkalingam, A., Gordon, S. C. WILEY. 2019: 302A–303A

View details for Web of Science ID 000488653501044